Fusion Pharmaceuticals Inc. Deferred Revenue
Fusion Pharmaceuticals Inc. had Deferred Revenue of $4.00 million as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2021-03-25
- 2020-12-31: Deferred Revenue $4.00M.
| Period end | Deferred Revenue |
|---|---|
| 2020-12-31 | $4.00M 10-K · filed 2021-03-25 |